News from IBG > Rare Disease Experts to Gather in İzmir
Rare Disease Experts to Gather in İzmir

Rare Disease Experts to Gather in İzmir

20 November 2026

Izmir Biomedicine and Genome Center (IBG) will host the European Network Conference on Chromatinopathies (EU-CHROMNet) on 25–27 November 2026. The conference aims to bring together researchers, clinicians, and patient representatives from different countries and lay the groundwork for establishing the first European research network dedicated to these rare genetic disorders.

What Are Chromatinopathies?

In our cells, DNA is wrapped around proteins called histones to form chromatin. The way chromatin is organized influences when and to what extent genes are expressed. Changes in the genes responsible for regulating this process can lead to rare disorders known as chromatinopathies. This group of conditions includes Cornelia de Lange syndrome and Kabuki syndrome, and may involve developmental delays, growth problems, and various organ abnormalities.

According to the European Commission, between 27 and 36 million people in the EU are living with a rare disease.

Research Agenda and Patient Priorities

The conference will address the underlying causes of chromatinopathies, diagnostic methods such as DNA sequencing, and stem cell models used in therapeutic research. During the roundtable discussion on 26 November, participants will discuss the establishment of a chromatinopathy working group within the European Reference Network ERN-ITHACA and identify shared research priorities.

The patient and family session on 27 November will feature David Axtell from CdLS Foundation UK & Ireland and Clara Tang from the Kabuki Syndrome Foundation. Discussions will focus on how the priorities of families can be reflected in research and how researchers can improve their communication with families.

Prof. Dr. Uğur Özbek (IBG), Chair of the Conference Scientific Committee, stated:

"Rare diseases, including chromatinopathies, affect many families in Türkiye. Progress in these conditions depends on scientists, clinicians, and patients working together. We are delighted to welcome this important community to İzmir for this meeting. We hope the conference will pave the way for new collaborations and research initiatives that will make a meaningful difference in the lives of families."

The conference is organized with the support of the Networking Support Scheme (NSS) of the European Rare Diseases Research Alliance (ERDERA) and co-funded by the European Union. Conference sponsors include PhiTech Bioinformatics and Massive Bioinformatics.

Conference programme: www.euchromnet2026.org

Conference secretariat: euchromnet2026@gmail.com 

About Izmir Biomedicine and Genome Center

IBG was established in 2018 under Law No. 6550 as Türkiye's first thematic research center. The Center conducts research in biomedicine and genome sciences, focusing on the prevention, diagnosis, and treatment of diseases.

RareBoost Project

Supported by the European Union's Horizon 2020 ERA Chairs programme, RareBoost aims to strengthen İBG's research and innovation capacity in the field of rare diseases. The project promotes national and international research collaborations and contributes to the organization of the EU-CHROMNet conference.

Rare and Undiagnosed Diseases Group

The group at IBG investigates the genetic and molecular causes of rare diseases and rare cancers. Using genomic analyses and disease models, it studies how diseases develop and works on identifying new biomarkers and developing therapeutic approaches.